Halobetasol Propionate
12 NDCs across 4 manufacturers|10 Generic,2 Brand
Halobetasol Propionate is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses and pruritus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 17, 1990, and the first generic was approved Dec 16, 2004. FDA's Orange Book lists 7 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $12 million on Halobetasol Propionate across 188,000 claims for 88,000 beneficiaries.
Halobetasol Propionate is available as 12 NDCs from 4 manufacturers (10 generic, 2 brand), with NADAC prices from $0.42 to $5.11 per GM — the most expensive product costs about 12× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
12
10G / 2B
Manufacturers
4
competing in market
Price Spread
$0.42 – $5.11
per GM
7d Activity
avg +0.5% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
4 manufacturers producing HALOBETASOL PROPIONATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BRYHALI 0.01% LOTION | $5.1099 per GM | — |
BRYHALI 0.01% LOTION | $5.1059 per GM | — |
HALOBETASOL PROP 0.05% OINTMNT | $0.8391 per GM | +9.43% |
HALOBETASOL PROP 0.05% OINTMNT | $0.8391 per GM | +9.43% |
HALOBETASOL PROP 0.05% OINTMNT | $0.8391 per GM | +9.43% |
HALOBETASOL PROP 0.05% CREAM | $0.6698 per GM | -5.01% |
HALOBETASOL PROP 0.05% CREAM | $0.6698 per GM | -5.01% |
HALOBETASOL PROP 0.05% OINTMNT | $0.4403 per GM | -4.07% |
HALOBETASOL PROP 0.05% OINTMNT | $0.4403 per GM | -4.07% |
HALOBETASOL PROP 0.05% OINTMNT | $0.4403 per GM | -4.07% |
HALOBETASOL PROP 0.05% CREAM | $0.4185 per GM | -0.51% |
HALOBETASOL PROP 0.05% CREAM | $0.4185 per GM | -0.51% |
Frequently Asked Questions
What is Halobetasol Propionate used to treat?
Halobetasol Propionate is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses and pruritus, per the National Library of Medicine's MED-RT classification.
When did Halobetasol Propionate become available as a generic?
FDA approved the first generic Halobetasol Propionate (ANDA) on Dec 16, 2004. The Orange Book currently lists 7 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Halobetasol Propionate?
In 2024, Medicare Part D spent $12 million on Halobetasol Propionate across 188,000 claims for 88,000 beneficiaries.
How many Halobetasol Propionate products are on the market?
The Halobetasol Propionate drug market contains 12 NDCs from 4 manufacturers — 10 generic and 2 brand products.
What is the price range for Halobetasol Propionate?
NADAC reference prices for Halobetasol Propionate range from $0.4185 to $5.1099 per GM — the most expensive product costs about 12× the cheapest.
Is generic Halobetasol Propionate cheaper than brand?
The average generic NADAC for Halobetasol Propionate is $0.6015 per GM, versus $5.1079 for brand-labeled products — brand versions average about 8.5× the generic price.
Which manufacturers make Halobetasol Propionate?
4 manufacturers list Halobetasol Propionate in NADAC. Ranked by number of NDCs, the largest are Cosette Pharmaceuticals, Inc. (4), Padagis Israel Pharmaceuticals Ltd (4), Bausch Health US LLC (2), Quagen Pharmaceuticals LLC (2).
How has the price of Halobetasol Propionate changed recently?
Over the past 7 days, 3 Halobetasol Propionate NDCs rose and 7 fell, with a market-wide average change of +0.5%.